首页> 外文期刊>Cell stress & chaperones >Chaperone co-inducer BGP-15 inhibits histone deacetylases and enhances the heat shock response through increased chromatin accessibility
【24h】

Chaperone co-inducer BGP-15 inhibits histone deacetylases and enhances the heat shock response through increased chromatin accessibility

机译:伴侣伴侣诱导剂BGP-15通过增加染色质的可及性抑制组蛋白脱乙酰基酶并增强热休克反应

获取原文
           

摘要

Defects in cellular protein homeostasis are associated with many severe and prevalent pathological conditions such as neurodegenerative diseases, muscle dystrophies, and metabolic disorders. One way to counteract these defects is to improve the protein homeostasis capacity through induction of the heat shock response. Despite numerous attempts to develop strategies for chemical activation of the heat shock response by heat shock transcription factor 1 (HSF1), the underlying mechanisms of drug candidates’ mode of action are poorly understood. To lower the threshold for the heat shock response activation, we used the chaperone co-inducer BGP-15 that was previously shown to have beneficial effects on several proteinopathic disease models. We found that BGP-15 treatment combined with heat stress caused a substantial increase in HSF1-dependent heat shock protein 70 (HSPA1A/B) expression already at a febrile range of temperatures. Moreover, BGP-15 alone inhibited the activity of histone deacetylases (HDACs), thereby increasing chromatin accessibility at multiple genomic loci including the stress-inducible HSPA1A. Intriguingly, treatment with well-known potent HDAC inhibitors trichostatin A and valproic acid enhanced the heat shock response and improved cytoprotection. These results present a new pharmacological strategy for restoring protein homeostasis by inhibiting HDACs, increasing chromatin accessibility, and lowering the threshold for heat shock response activation.
机译:细胞蛋白稳态的缺陷与许多严重和普遍的病理状况有关,例如神经退行性疾病,肌肉营养不良和代谢异常。解决这些缺陷的一种方法是通过诱导热激反应来提高蛋白质体内平衡能力。尽管进行了许多尝试来开发通过热休克转录因子1(HSF1)化学激活热休克反应的策略的尝试,但对于候选药物作用方式的潜在机制知之甚少。为了降低热休克反应激活的阈值,我们使用了伴侣伴侣诱导剂BGP-15,该伴侣先前已证明对几种蛋白病性疾病模型具有有益作用。我们发现,BGP-15处理与热应激相结合已经在温热的温度范围内大幅增加了HSF1依赖性热激蛋白70(HSPA1A / B)的表达。此外,BGP-15单独抑制组蛋白脱乙酰基酶(HDACs)的活性,从而增加了包括应激诱导型HSPA1A在内的多个基因组位点的染色质可及性。有趣的是,用著名的强效HDAC抑制剂曲古抑菌素A和丙戊酸治疗可增强热休克反应并改善细胞保护作用。这些结果提出了通过抑制HDAC,增加染色质可及性和降低热休克反应激活阈值来恢复蛋白质稳态的新药理策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号